ESTRELLA IMMUNOPHARMA ACTIVATES UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER AS FOURTH CLINICAL SITE FOR PHASE I/II STARLIGHT-1 TRIAL IN B-CELL NON-HODGKIN’S LYMPHOMA

Reuters · 3d ago

Please log in to view news